Metabolic Profile and Body Composition in Adult Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 31 of the 34 references it cites were found in a registry or an index.
Abstract
CONTEXT: The chronic, often supraphysiological glucocorticoid doses used in congenital adrenal hyperplasia (CAH) might increase morbidity in cardiovascular disease and diabetes. OBJECTIVE: Our aim was to assess risk factors for cardiovascular disease and diabetes in CAH women. SUBJECTS, METHODS, AND DESIGN: We compared 61 women, 18-63 yr, with CAH due to 21-hydroxylase deficiency with 61 age- and sex- matched controls. Twenty-seven were younger than 30 yr, and 34 were 30 yr or older. Anthropometry, fat and lean mass measured by dual-energy x-ray absorptiometry, serum lipids, insulin, and adrenocortical steroids were studied. MAIN OUTCOME MEASURE: Body composition and cardiovascular risk factors were the main outcome measures. RESULTS: Younger patients and controls had similar waist to hip ratio, lean and fat mass, and insulin. Older patients had higher waist to hip ratio, lean mass, and insulin than controls. Fat mass was similar to controls but higher than in younger patients. Lipid profiles were slightly more favorable in older patients than controls. Gestational diabetes was more common in patients (21% of pregnancies vs. 0, P < 0.026). Few older patients had hypertension, cardiovascular disease, or diabetes. Despite moderate glucocorticoid doses, most patients had suppressed androgens. CONCLUSIONS: No clear evidence of unfavorable cardiovascular risk factors were found. Increased fat mass and higher insulin levels were, however, found in patients older than 30 yr. High frequency of gestational diabetes is a risk marker for future diabetes. Lifelong follow-up, lifestyle modifications, and attempts to adjust and reduce the glucocorticoid doses seem important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Women with CAH are often overweight (202, 203, 260), but patients with CAH .30years of age had similar fat mass to age-matched controls.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of overweight and obesity are greater in adults with CAH in the UK (360) and Sweden (671) but similar to the general population in the US (217) and France (626,672).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [672]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Women with CAH may be at increased risk for gestational diabetes (257, 260).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [260]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Mazess, R., Barden, H., Bisek, J., & Hanson, J. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,476
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
KANNEL, W. B., CASTELLI, W. P., & GORDON, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,311
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Congenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Sex steroids and insulin resistance
LIVINGSTONE, C., & COLLISON, M. (2002) · Clinical Science · doi:10.1042/cs1020151 · Cited by 309
Cited by
Items 101–166 of 166
Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia
Kim, M. S., Fraga, N. R., Minaeian, N., & Geffner, M. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.848274 · Cited by 25
“Combined with emerging reports of type 2 diabetes, gestational diabetes, and adverse cardiac events in adults with classical CAH (20, 52, 53), further longitudinal study of this highrisk cohort is merited to assess risk factors from childhood through adulthood, to better understand the development of longer-term adver…”
BackgroundHormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bachelot, A., Chakhtoura, Z., Rouxel, A., Dulon, J., & Touraine, P. A. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.019 · Cited by 20
Management of the Adult with Congenital Adrenal Hyperplasia
Auchus, R. J. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/614107 · Cited by 17
“In fact, children [29] and adults [30] with 21-OHD are prone to develop hypertension, prompting reduction or rarely discontinuation of mineralocorticoid dosing, or the paradoxical need for antihypertensive drugs plus fludrocortisone acetate.”
Mnif, M. F., Kamoun, M., Mnif, F., Charfi, N., Naceur, B. B., Kallel, N., Rekik, N. M., Mnif, Z., Sfar, M. H., Sfar, M., et al. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.102995 · Cited by 18
Identity, sexuality, and parenthood in women with congenital adrenal hyperplasia
Engberg, H., Möller, A., Hagenfeldt, K., Nordenskjöld, A., & Frisén, L. (2020) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2020.05.005 · Cited by 15
Nygren, U., Isberg, B., Arver, S., Hertegård, S., Södersten, M., & Nordenskjöld, A. (2016) · Journal of Speech Language and Hearing Research · doi:10.1044/2016_jslhr-s-14-0191 · Cited by 15
“In women with CAH, another effect of excessive exposure to androgens is hampered growth, so these women are at risk for being shorter than age-matched controls (Falhammar et al., 2007).”
BackgroundClinical outcomes in 21-hydroxylase deficiency
Nordenström, A., Lajić, S., & Falhammar, H. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000625 · Cited by 15
“Androstenedione levels may be a better and more durable marker for control in 21OHD [3,14,64], but unfortunately nevanimibe failed to effectively suppress androstenedione [63 & ].”
BackgroundGrunt, S., Steinlin, M., Weisstanner, C., Schöning, M., Mullis, P. E., & Flück, C. E. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348515 · Cited by 13
Righi, B., Ali, S., Bryce, J., Tomlinson, J., Bonfig, W., Baronio, F., Costa, E. C., Guaragna‐Filho, G., T'Sjoen, G. G., Cools, M., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03330-w · Cited by 15
Charoensri, S., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad628 · Cited by 13
Cardiovascular Risk Factors in Children and Adolescents with Congenital Adrenal Hyperplasia
Dehkordi, E. H., Khaheshi, S., Mostofizadeh, N., & Hashemipour, M. (2021) · Advanced Biomedical Research · doi:10.4103/abr.abr_219_20 · Cited by 13
“[35] Similar to our results, Roche et al.[26] and Völkl et al.[33] reported the prevalence of overweight and obesity as a main risk factor in children and adolescents with CAH.”
BackgroundInfluentialGotby, A. O., Nordenström, A., Falhammar, H., Nordenskjöld, A., Hirschberg, A. L., Frisén, L., Landén, M., & Lichtenstein, P. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.008 · Cited by 14
Lim, S. G., Lee, Y. A., Jang, H. N., Kong, S. H., Ahn, C. H., Kim, S. W., Shin, C. H., & Kim, J. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761258 · Cited by 13
“suggested that older women with CAH had also higher lean mass which may explain the favorable lipid profile (20).”
BackgroundHealth-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia
Zainuddin, A. A., Grover, S. R., Ghani, N. A. A., Wu, L. L., Rasat, R., Manaf, M. R. A., Shamsuddin, K., & Mahdy, Z. A. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01515-9 · Cited by 11
Borges, J. H., de Oliveira, D. M., de Lemos‐Marini, S. H. V., Geloneze, B., Gonçalves, E. M., & Guerra‐Júnior, G. (2020) · Lipids · doi:10.1002/lipd.12280 · Cited by 12
Gonçalves, E. M., Silva, A. M., Santos, D. A., de Lemos‐Marini, S. H. V., Santos, A. O., Mendes-dos-Santos, C. T., de Mello, M. P., & Guerra‐Júnior, G. (2012) · Nutrition · doi:10.1016/j.nut.2011.12.014 · Cited by 8
“Adults with CAH present higher BMI levels and higher fat mass compared with control subjects [34,35], but older patients (age >30 y) had a higher BMI and similar body fat, but higher lean mass, than controls [36].”
BackgroundClausen, C. S., Ljubicic, M. L., Main, K. M., Andersson, A.-M., Petersen, J. H., Frederiksen, H., Duno, M., Johannsen, T. H., & Juul, A. (2020) · Hormone Research in Paediatrics · doi:10.1159/000509079 · Cited by 7
Metabolic evaluation of young women with congenital adrenal hyperplasia
Schnaider, G. S., de Lemos‐Marini, S. H. V., Baptista, M. T. M., Guerra‐Júnior, G., Morcillo, A. M., de Mello, M. P., de Oliveira, L. C., & D’Souza-Li, L. F. R. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000800021 · Cited by 7
“Adrenomedullary dysfunction and intermittent hypercortisolism are linked to these abnormalities, which predispose these patients to a higher risk of metabolic syndrome and atherosclerosis (1,8-20).”
BackgroundJiang, S., & Kuang, Y. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0893-3122 · Cited by 7
“This finding is in accordance with a previous research [24] but different from some other observations, in which the women present an obviously higher BMI than population mean [14, 15, 25].”
ResultCongenital adrenal hyperplasia in adolescence — a gynecological perspective
Oliveira, J. C., Sousa, F. C., Campos, S. T., Geraldes, F. B., Belo, J. L., Leite, M. H., Mirante, M. A., & Águas, M. F. (2022) · Ginekologia Polska · doi:10.5603/gp.a2021.0248 · Cited by 8
Majeed, M. W., Finnegan, E. A., Ruelas, M. G., Quirós, M., da Silva, M. B., Salha, I., Herrán-Fonseca, C., de Oliveira, H. M., Quirós, M. C., Ahmed, R., et al. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100247 · Cited by 5
Falhammar, H., Hirschberg, A. L., Nordenskjöld, A., Larsson, H., & Nordenström, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad624 · Cited by 5
Cardiovascular risk in Cuban adolescents and young adults with congenital adrenal hyperplasia
Reyes, T. M. E., Velepucha, A. K. P., Rego, J. O. C., Gómez, W. V., Alonso, E. D., & Falhammar, H. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01499-9 · Cited by 5
“In relation to the biochemical parameters, the lower fasting glucose concentrations in patients with CAH compared to controls is probably a sign of cortisol insufficiency in the morning and have also been reported in other studies [9, 13].”
ResultChanges in resting-state functional connectivity in patients with congenital adrenal hyperplasia
Messina, V., Westeinde, A. V., Padilla, N., & Lajić, S. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103081 · Cited by 5
“Thus, patients with CAH may experience episodes of over- or under-treatment, with a risk of adverse effects on metabolism (Volkl et al., 2006; Falhammar et al., 2007; Falhammar et al., 2011), cognition (Johannsen et al., 2006; Browne et al., 2015; Karlsson et al., 2017); behaviour (Pasterski et…”
Nygren, U. (2014) · Figshare · Cited by 7
Gonçalves, E. M., de Lemos‐Marini, S. H. V., de Mello, M. P., Baldin, A. D., de Carvalho, W. R. G., Farias, E. S., & Guerra‐Júnior, G. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000300005 · Cited by 8
“A maior parte dos estudos que investigaram a composição corporal em indivíduos com HAC utilizou o DXA para a avaliação (20,21,24,26).”
BackgroundHiperplasia adrenal congênita em mulheres adultas: manejo de antigos e novos desafios
Costa‐Barbosa, F. A., Silveira, M. T., & Kater, C. E. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002987 · Cited by 9
“No entanto, ainda não foi demonstrada maior morbidade ou mortalidade cardiovascular ou risco de diabetes tipo 2 nessas mulheres (9).”
BackgroundWomen’s response regarding timing of genital surgery in congenital adrenal hyperplasia
Falhammar, H., Holmdahl, G., Nyström, H. F., Nordenström, A., Hagenfeldt, K., & Nordenskjöld, A. (2024) · Endocrine · doi:10.1007/s12020-024-04080-z · Cited by 3
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00025-1 · Cited by 3
TUHAN, H., Öztürk, T., Çatlı, G., Acar, S., Abacı, A., Egeli, T. Ü., Demir, K., Can, Ş., Güleryüz, H., Dündar, B. N., et al. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2001-57 · Cited by 3
Metabolic disorders in the adult patients presenting with congenital adrenal hyperpl
Игоревна, С. А., Troshina, E. A., & Молашенко, Н. В. (2012) · Problems of Endocrinology · doi:10.14341/probl20125853-9 · Cited by 4
Tantbírójn, P., Taweevisit, M., Sritippayawan, S., & Uerpairojkit, B. (2008) · Journal of Medical Case Reports · doi:10.1186/1752-1947-2-251 · Cited by 3
“It is well documented that congenital hyperplasia may be the cause of hyperglycemia or diabetes [10], but hyperglycemia cannot explain the pathogenesis of adrenal hyperplasia in this case.”
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00024-x · Cited by 5
Congenital adrenal hyperplasia
Krone, N. P. (2011) · doi:10.1093/med/9780199235292.003.0616 · Cited by 3
Bulsari, K., & Falhammar, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65823-3 · Cited by 3
Carrière, C., Sarfati, C., Téjédor, I., Dulon, J., Chakhtoura, Z., Courtillot, C., & Bachelot, A. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.007 · Cited by 3
Podgórski, R., Podgórska, D., & Sumińska, M. (2023) · Pediatria Polska · doi:10.5114/polp.2023.133534 · Cited by 2
“More recently, modified-release hydrocortisone formulations have been introduced and experimental studies have been conducted with subcutaneous infusion systems [52, 111], which have been shown to better mimic the circadian rhythm in classic CAH.”
BackgroundCongenital adrenal hyperplasia in adults
Lin‐Su, K., Nimkarn, S., & New, M. I. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.1.67 · Cited by 2
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00023-1 · Cited by 2
Shifman, B. M., Dzeranova, L. K., Pigarova, E. A., Tiulpakov, A. N., & Fedorova, N. S. (2019) · Obesity and metabolism · doi:10.14341/omet10032 · Cited by 3
Long-Term Outcome of Disorders of Sex Development (DSD): A World View
Warne, G. L. (2011) · Springer eBooks · doi:10.1007/978-3-642-22964-0_26 · Cited by 4
Transition of pediatric endocrine patients to adult care
Kamboj, M. K., Greydanus, D. E., Bricker, L. A., & Patel, D. R. (2010) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2010.025 · Cited by 1
Management of Giant Bilateral Adrenal Myelolipomas in Congenital Adrenal Hyperplasia
Purohit, A., & Rappaport, M. J. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf169 · Cited by 1
“However, in adults with CAH, CT imaging can often reveal adrenal masses, especially among those on inconsistent pharmacological therapy [12].”
Молашенко, Н. В., Игоревна, С. А., Troshina, E. A., & Калинченко, Н. Ю. (2010) · Problems of Endocrinology · doi:10.14341/probl201056515-22 · Cited by 1
“В большинстве работ [16, 20—22, 24, 31, 36—39] у пациентов с ВДКН обнаружена тенденция к развитию гиперинсулинемии и ИР, ряд исследований в ходе проведения ПГТТ выявили нарушение толерантности к глюкозе, преимущественно в возрастной группе старше 30 лет [24, 26].”
InfluentialAnthropometry in Congenital Adrenal Hyperplasia
Falhammar, H., Nordenström, A., & Thorén, M. C. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1788-1_146 · Cited by 1
Janin, C., Vigneron, V., Weryha, G., & Leheup, B. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.10.003
Unravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Nermoen, I. (2013) · NVA (Nasjonalt vitenarkiv)
Moreira, R. P. P. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-01042016-161323
LE DEFICIT CONGENITAL EN 21 HYDROXYLASE SUIVI CHEZ LA FEMME ADULTE
de Médecine, F. (2012)
Monitoring of vascular health in children at risk for atherosclerosis.
Harrington, J. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Nationellt miljökvalitetsmål på lokal nivå
Engkvist, F. (2011)
Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia
Zainuddin, A. A., Grover, S. R., Abdul Ghani, N. A., Ll, W., Rasat, R., Abdul Manaf, M. R., Shamsuddin, K., & Mahdy, Z. A. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.13.9
Congenital Adrenal Hyperplasia
Abraham, S. B., & Merke, D. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_5
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283040e80
Management of Adult Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Grouthier, V., Dulon, J., Bachelot, A., & Touraine, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66140-8
Breakthroughs in Congenital Adrenal Hyperplasia Care – Hope on the Horizon
Raizada, N., & Madhu, S. V. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_333_24
“[13,14] Some data suggest that adolescents and young adults with CAH have more abdominal and visceral obesity as compared to controls.”
BackgroundEndocrinological Outcomes in Subjects with DSD
Misra, S., Gada, J. V., & Bhagwat, N. M. (2024) · Springer eBooks · doi:10.1007/978-981-97-1639-5_46
Management of adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Grouthier, V., Dulon, J., Bachelot, A., & Touraine, P. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00132-1
Medical and social challenges awaiting adolescents with congenital adrenal hyperplasia
Nixon, M., & Davies, J. H. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1870467
El-Taravi, Y., Ebanoidze, L. G., Vorotnikova, S. Y., Vorontsova, M. V., Игоревна, С. А., & Молашенко, Н. В. (2026) · Russian Journal of Human Reproduction · doi:10.17116/repro202632041124
Metadata
- Authors
- Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M.
- Affiliations
- Karolinska University Hospital (SE)
- Department of Endocrinology (H.Fi.), Sahlgrenska University Hospital and Sahlgrenska Academy, SE-413 45 Gothenburg, Sweden
- Drottning Silvias barn- och ungdomssjukhus (SE)
- Sahlgrenska University Hospital (SE)
- Department of Molecular Medicine and Surgery (H.Fa., A.N., M.T.), Karolinska University Hospital and Karolinska Institute, SE-171 76 Stockholm, Sweden
- Department of Endocrinology, Metabolism, and Diabetes (H.Fa., M.T.), Karolinska University Hospital and Karolinska Institute, SE-171 76 Stockholm, Sweden
- Corresponding author
- Falhammar, Henrik
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-01-01
- Volume
- 92
- Issue
- 1
- Pages
- 110-116
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2124458165
- Cited by
- 167
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 4 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 13 · 2012: 11
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Göteborgs Läkaresällskap
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, body composition, fat mass, lean body mass, waist-to-hip ratio, insulin, cardiovascular risk factors, diabetes risk, gestational diabetes mellitus, glucocorticoid dose, androgen deprivation therapy, serum lipids, women
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Blood Pressure, Body Composition, Body Weight, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Middle Aged, Steroid 21-Hydroxylase, Body Mass Index, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.